Suppr超能文献

恶性疟原虫体外连续培养条件:在整个红内无性生殖生命周期中对疟原虫敏感性和抗疟药物耐受性的比较。

Plasmodium falciparum in vitro continuous culture conditions: A comparison of parasite susceptibility and tolerance to anti-malarial drugs throughout the asexual intra-erythrocytic life cycle.

机构信息

Discovery Biology, Griffith Institute for Drug Discovery, Griffith University, Nathan, Queensland, 4111, Australia.

Discovery Biology, Griffith Institute for Drug Discovery, Griffith University, Nathan, Queensland, 4111, Australia.

出版信息

Int J Parasitol Drugs Drug Resist. 2017 Dec;7(3):295-302. doi: 10.1016/j.ijpddr.2017.07.001. Epub 2017 Jul 15.

Abstract

The continuous culture of Plasmodium falciparum is often seen as a means to an end, that end being to probe the biology of the parasite in question, and ultimately for many in the malaria drug discovery arena, to identify means of killing the parasite in order to treat malaria. In vitro continuous culture of Plasmodium falciparum is a fundamental requirement when undertaking malaria research where the primary objectives utilise viable parasites of a desired lifecycle stage. This investigation, and resulting data, compared the impact culturing Plasmodium falciparum long term (4 months) in different environmental conditions had on experimental outcomes and thus conclusions. The example presented here focused specifically on the effect culture conditions had on the in vitro tolerance of Plasmodium falciparum to standard anti-malarial drugs, including artemisinin and lumefantrine. Historical data from an independent experiment for 3D7-ALB (5% O) was also compared with that obtained from this study. We concluded that parasites cultured for several months in media supplemented with a serum substitute such as Albumax II or within hyperoxic conditions (21% O), demonstrate highly variable responses to artemisinin and lumefantrine but not all anti-malarial drugs, when compared to those cultured in human serum in combination with Albumax II under normoxic conditions (5% O) for the parasite.

摘要

恶性疟原虫的连续培养通常被视为一种手段,目的是探究寄生虫的生物学特性,最终对于疟疾药物发现领域的许多人来说,是为了确定杀死寄生虫的方法以治疗疟疾。在进行疟疾研究时,体外连续培养恶性疟原虫是一项基本要求,主要目标是利用所需生命周期阶段的有活力寄生虫。本研究比较了在不同环境条件下长期(4 个月)培养恶性疟原虫对实验结果和结论的影响。这里介绍的示例特别关注培养条件对恶性疟原虫体外抗疟药物(包括青蒿素和咯萘啶)耐受的影响。还比较了来自独立 3D7-ALB(5% O )实验的历史数据与本研究获得的数据。我们得出的结论是,与在含血清替代物(如 Albumax II)的培养基中或在高氧条件(21% O)下培养几个月的寄生虫相比,在含血清的培养基中与 Albumax II 一起在常氧条件(5% O)下培养的寄生虫对青蒿素和咯萘啶表现出高度可变的反应,但并非所有抗疟药物都是如此。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7fd/5522918/8e867ebca5c4/fx1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验